Sydney, Feb 25, 2026, 17:26 AEDT — After-hours
- CSL eked out a modest gain, halting its two-session decline.
- The latest ASX filing lays out the day’s share buyback numbers in detail.
- Attention now turns to whether the buyback actually happens, plus March’s ex-dividend date looms.
CSL Ltd (CSL.AX) picked up 0.08% to close at A$145.11 on Wednesday, snapping a two-day losing streak. Shares have dropped roughly 20% since early February. During the session, they bounced between A$144.64 and A$146.49, Investing.com data show. (Investing)
The move is minor, yet with CSL shares volatile and under pressure, investors remain unsure just where “support” might settle for the stock at this stage.
The tape’s twitchy now, moving on modest, repetitive flows: buybacks, traders jockeying for dividends, and the latest hint that management’s second-half strategy might actually stick.
CSL reported in an ASX filing that it snapped up 83,519 shares on Feb. 24, spending A$12.2 million at prices ranging from A$145.00 to A$148.29 apiece. The on-market buyback, executed through the exchange, will continue until June 30 and aims for a total of up to US$750 million.
CSL posted a net profit after tax of US$401 million for the half-year to Dec. 31, a sharp 81% drop, hammered by one-off restructuring charges and impairments—accounting write-downs slashing the bottom line. “Clearly not satisfied with our performance,” Chief Financial Officer Ken Lim said, as CSL left its full-year outlook unchanged. (CSL Limited)
Interim chief Gordon Naylor echoed the sentiment, making it clear he wasn’t willing to concede that the business “can’t do better”. Over at Citi, analysts flagged the tight outlook, warning there’s little room for missteps—and that CSL’s Behring arm is expected to carry much of the load for the second half. (Reuters)
Still, buybacks alone aren’t a cure-all for operational worries. Any slip in plasma demand, pricing, or supply—or if Seqirus faces yet another soft U.S. flu season—could easily outweigh that buyback boost and leave the stock stuck where it is.
CSL announced an interim dividend of US$1.30 per share. Shares go ex-dividend March 10—investors picking up the stock after that date won’t get the payout. Payment lands April 9, and the final Aussie dollar figure is scheduled for release March 13.
Market’s closed, so attention shifts to Thursday—traders want to see if shares hold above this week’s lows. Another watchpoint: whether that buyback keeps surfacing in the daily numbers.
March 10 is the key date—CSL trades ex-dividend then. Watch for any news on leadership changes or guidance about second-half demand; either could shift the stock ahead of that deadline.
